Navigation

Skiplink Navigation

Main Features

Health warnings Seizures of illegally imported medicines triple in Switzerland

Drugs seized by Swissmedic

Last year Swissmedic and the Swiss customs officers seized 15 illegal shipments of Xanax from Cambodia, Hungary and other countries

(Swissmedic)

The Federal Customs Administration seized 3,203 shipments of illegally imported medicines in 2018 – triple the amount of the previous year. 

Erectile stimulants remain at the top of the list of illegally imported substances, the Swiss Agency for Therapeutic Products (Swissmedic) said on Thursdayexternal link

These were followed by sleeping, diet and hair growth pills, the statement added. 

Like in 2017, the majority of illegal shipments were from India (42%), followed by Eastern Europe (32%) and Asia (mainly Singapore, 17.5%). 

The huge increase in seizures last year is partly due to more intensive collaboration between the different authorities, and a simplified working procedure between the Federal Customs Administration and Swissmedic. 

Imports of Xanax, an anxiolytic drug, bought illegally on the Internet and via the darknet are worrying, the Swiss agency said. Its active ingredient alprazolam is a member of the benzodiazepine group and is subject to drug regulations. In recent years, it has been increasingly misused as a recreational drug and can be very addictive. 

Last year, Swissmedic and customs seized 15 illegal shipments of Xanax from Cambodia, Hungary and other countries. According to information from the manufacturer of the original preparation, more than 95% of Xanax preparations sold illegally are counterfeit. 

Swissmedic urges people to be particularly wary of buying counterfeit medicines online which may be poor quality and represent a health risk. 

Keystone SDA/sb

Neuer Inhalt

Horizontal Line


SWI swissinfo.ch on Instagram

SWI swissinfo.ch on Instagram

SWI swissinfo.ch on Instagram

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.









Click here to see more newsletters